Tempest Therapeutics Names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec.
Position
CFO, Treasurer, & Corp Sec.
Company
Tempest Therapeutics
BrisbaneBiotechnologyHealthcareHealth CareTherapeuticsBiopharmaDescription
Stephanie Horn-Warnock became CFO, Treasurer, & Corp Sec. of Tempest Therapeutics on October 26, 2026, per the SEC Form 3 filed November 3, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
Quick answer
Tempest Therapeutics Names Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec. (November 4, 2026). Tempest Therapeutics is based in Brisbane, California, United States.
- Who is the new CFO, Treasurer, & Corp Sec. at Tempest Therapeutics?
- Tempest Therapeutics named Stephanie Horn-Warnock CFO, Treasurer, & Corp Sec., announced November 4, 2026.
- What did Tempest Therapeutics announce on November 4, 2026?
- Stephanie Horn-Warnock became CFO, Treasurer, & Corp Sec. of Tempest Therapeutics on October 26, 2026, per the SEC Form 3 filed November 3, 2026. A Form 3 is the first ownership report a new officer files, due within 10 days of taking the role.
- What does Tempest Therapeutics do?
- Tempest Therapeutics is a development-stage biotechnology company.
- Where is Tempest Therapeutics based?
- Tempest Therapeutics is based in Brisbane, California, United States.
- Which similar companies made leadership changes around the same time?
- AbbVie Inc. (November 2, 2026), Retension Pharmaceuticals (October 23, 2026), Gyre Therapeutics (October 22, 2026) and Verastem Oncology (October 14, 2026) also announced leadership changes within 45 days of Tempest Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
- Verastem Oncology Appoints Michael P. Bailey as Chief Executive Officer (October 14, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
Who to call at Tempest Therapeutics, and when
A new leader at Tempest Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Tempest Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Tempest Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Tempest Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Tempest Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Tempest Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.